Who has invested in City Therapeutics?

Arch Venture Partners are named among the investors backing City Therapeutics.

City Therapeutics Funding: $235M Raised, Series A (2025)

City Therapeutics funding overview

City Therapeutics is a Biotech company based in Cambridge. City Therapeutics has raised $235M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in July 2025. The round record for City Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Arch Venture Partners.

City Therapeutics at a glance

Total raised: $235M
Latest round: Series A
Latest round date: July 2025
Industry: Biotech
Headquarters: Cambridge
Notable investors: Arch Venture Partners

Frequently asked about City Therapeutics funding

How much has City Therapeutics raised?: City Therapeutics has raised $235M in total disclosed funding across the rounds on record.
Who has invested in City Therapeutics?: Arch Venture Partners are named among the investors backing City Therapeutics.
What was the latest City Therapeutics funding round?: The most recent disclosed round is a Series A, announced in July 2025.
Where is City Therapeutics based?: City Therapeutics is based in Cambridge.
What sector does City Therapeutics operate in?: City Therapeutics is tracked under Biotech from Cambridge, with $235M in disclosed funding.
When did City Therapeutics last raise?: The last disclosed City Therapeutics round closed in July 2025 at Series A.

City Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Cambridge below to benchmark round size and investor mix.

City Therapeutics Funding: $235M Raised, Series A (2025)

City Therapeutics funding overview

City Therapeutics at a glance

Frequently asked about City Therapeutics funding

City Therapeutics founders (1)

Companies related to City Therapeutics (40)

Browse related funding lists (6)